Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The human T cell immune response to Epstein-Barr virus.
Landais E, Saulquin X, Houssaint E. Landais E, et al. Among authors: houssaint e. Int J Dev Biol. 2005;49(2-3):285-92. doi: 10.1387/ijdb.041947el. Int J Dev Biol. 2005. PMID: 15906243 Free article.
Identification of a gp100 epitope recognized by HLA-A3 restricted melanoma infiltrating lymphocytes.
Moreau-Aubry A, Fonteneau J, Labarriere N, Jotereau F, Houssaint E, Breathnach R. Moreau-Aubry A, et al. Among authors: houssaint e. Int J Oncol. 1997 Apr;10(4):841-6. Int J Oncol. 1997. PMID: 21533454
Immunodominant CD8 T cell response to Epstein-Barr virus.
Houssaint E, Saulquin X, Scotet E, Bonneville M. Houssaint E, et al. Biomed Pharmacother. 2001 Sep;55(7):373-80. doi: 10.1016/s0753-3322(01)00082-8. Biomed Pharmacother. 2001. PMID: 11669500 Review.
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.
Long HM, Haigh TA, Gudgeon NH, Leen AM, Tsang CW, Brooks J, Landais E, Houssaint E, Lee SP, Rickinson AB, Taylor GS. Long HM, et al. Among authors: houssaint e. J Virol. 2005 Apr;79(8):4896-907. doi: 10.1128/JVI.79.8.4896-4907.2005. J Virol. 2005. PMID: 15795275 Free PMC article.
T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.
Scotet E, David-Ameline J, Peyrat MA, Moreau-Aubry A, Pinczon D, Lim A, Even J, Semana G, Berthelot JM, Breathnach R, Bonneville M, Houssaint E. Scotet E, et al. Among authors: houssaint e. J Exp Med. 1996 Nov 1;184(5):1791-800. doi: 10.1084/jem.184.5.1791. J Exp Med. 1996. PMID: 8920867 Free PMC article.
Epstein-Barr virus and rheumatoid arthritis.
Bonneville M, Scotet E, Peyrat MA, Saulquin X, Houssaint E. Bonneville M, et al. Among authors: houssaint e. Rev Rhum Engl Ed. 1998 Jun;65(6):365-8. Rev Rhum Engl Ed. 1998. PMID: 9670326 Review. No abstract available.
Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: evidence for a TAP-independent processing.
Saulquin X, Bodinier M, Peyrat MA, Hislop A, Scotet E, Lang F, Bonneville M, Houssaint E. Saulquin X, et al. Among authors: houssaint e. Eur J Immunol. 2001 Mar;31(3):708-15. doi: 10.1002/1521-4141(200103)31:3<708::aid-immu708>;2-5. Eur J Immunol. 2001. PMID: 11241274
A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening.
Saulquin X, Ibisch C, Peyrat MA, Scotet E, Hourmant M, Vie H, Bonneville M, Houssaint E. Saulquin X, et al. Among authors: houssaint e. Eur J Immunol. 2000 Sep;30(9):2531-9. doi: 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O. Eur J Immunol. 2000. PMID: 11009086
The T cell repertoire selected in vitro against EBV: diversity, specificity, and improved purification through early IL-2 receptor alpha-chain (CD25)-positive selection.
Ibisch C, Saulquin X, Gallot G, Vivien R, Ferrand C, Tiberghien P, Houssaint E, ViƩ H. Ibisch C, et al. Among authors: houssaint e. J Immunol. 2000 May 1;164(9):4924-32. doi: 10.4049/jimmunol.164.9.4924. J Immunol. 2000. PMID: 10779803
Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.
de la Salle H, Houssaint E, Peyrat MA, Arnold D, Salamero J, Pinczon D, Stevanovic S, Bausinger H, Fricker D, Gomard E, Biddison W, Lehner P, UytdeHaag F, Sasportes M, Donato L, Rammensee HG, Cazenave JP, Hanau D, Tongio MM, Bonneville M. de la Salle H, et al. Among authors: houssaint e. J Immunol. 1997 May 15;158(10):4555-63. J Immunol. 1997. PMID: 9144467
71 results
Jump to page